Profil
Christopher D.
Galloway worked as a Medical Affairs Director at Merck & Co., Inc. from 2016 to 2018, followed by a position as Senior Medical Director-Medical Affairs at La Jolla Pharmaceutical Co. from 2018 to 2020.
He also worked as a Medical Director at DaVita Clinical Research and as a Medical Director-Global Clinical Development at Rakuten Medical, Inc. from 2016 to 2018.
Currently, he is the Chief Medical Officer at Diffusion Pharmaceuticals, Inc. Dr. Galloway received his undergraduate degree from The University of Texas at Austin and his doctorate from the University of Texas Medical Branch.
Anciens postes connus de Christopher Galloway
| Sociétés | Poste | Fin |
|---|---|---|
| DIFFUSION PHARMA | Directeur Technique/Scientifique/R&D | 01/03/2023 |
| LA JOLLA PHARMACEUTICAL COMPANY | Directeur Technique/Scientifique/R&D | 01/09/2020 |
| MERCK & CO., INC. | Directeur Technique/Scientifique/R&D | 01/07/2018 |
Rakuten Medical, Inc.
Rakuten Medical, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops and commercializes precision & cell-targeting photoimmunotherapy | Corporate Officer/Principal | 01/01/2018 |
DaVita Clinical Research
DaVita Clinical Research Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DaVita Clinical Research is a provider of late-phase (phase II-IV) clinical trial services specializing in renal diseases, particularly chronic kidney disease and end-stage kidney disease. The American company utilizes real-world electronic medical record data and a network of principal investigators to design protocols, optimize site selection, and efficiently enroll patients. Its integrated, provider-based research site network includes standardized training, centralized contracting, and expedited feasibility assessments to support rapid study start-up and high-quality execution. DaVita Clinical Research operates internationally, supporting nephrology and diabetes clinical trials, and assists pharmaceutical and medical device companies in the design, recruitment, and completion of clinical trials using its renal research site network. | Directeur Technique/Scientifique/R&D | - |
Formation de Christopher Galloway
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Texas Medical Branch
University of Texas Medical Branch Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DaVita Clinical Research
DaVita Clinical Research Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DaVita Clinical Research is a provider of late-phase (phase II-IV) clinical trial services specializing in renal diseases, particularly chronic kidney disease and end-stage kidney disease. The American company utilizes real-world electronic medical record data and a network of principal investigators to design protocols, optimize site selection, and efficiently enroll patients. Its integrated, provider-based research site network includes standardized training, centralized contracting, and expedited feasibility assessments to support rapid study start-up and high-quality execution. DaVita Clinical Research operates internationally, supporting nephrology and diabetes clinical trials, and assists pharmaceutical and medical device companies in the design, recruitment, and completion of clinical trials using its renal research site network. | Health Services |
Diffusion Pharmaceuticals, Inc.
Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapies | Health Technology |
Rakuten Medical, Inc.
Rakuten Medical, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops and commercializes precision & cell-targeting photoimmunotherapy | Health Technology |
















